First GlaxoSmithKline ResearchKit Study Goes Live

[Maura]

One year on from the announcement that Apple was making ResearchKit available to major pharmaceutical companies such as GlaxoSmithKline (GSK), GSK has announced that the first of its ResearchKit studies is going live.

Using the GSK PARADE iPhone app, the study will conduct surveys and use iPhone sensors to collect and keep track of common rheumatoid arthritis symptoms, such as joint pain, fatigue, and mood. It will also track activity and quality-of-life measures for 300 patients over a 3-month period.

“Our goal is to engage with patients in a new way that integrates the research into their daily lives versus the traditional model that requires patients to travel to their doctors’ offices,” said a GSK statement on the study. “ResearchKit [enables us to] gather data more frequently and more accurately from participants using an iPhone.”

If you’re someone who has rheumatoid arthritis and want to participate in the study (and provided you are over 21 and in the US), you can download the app from the App Store to apply.

Click here to download: GSK PARADE on the App Store

Source: A year after announcement, first big pharma study using Apple’s ResearchKit goes live